Jun Wu

Jun Wu was the founder of Shanghai Genomics, Inc. (founded in 2001) where he served as the Chief Executive Officer from 2001 to 2005.
He currently holds multiple positions including Chairman at Cenova Ventures, Director at Vivace Therapeutics, Inc., Director at Suzhou Jingyi Healthcare Equipement Co., Ltd., Director at Luqa Ventures Co. Ltd., Director at Novoasis Investment Ltd., Director at Shanghai Birdie Biotech Ltd., Director at Etongonline Shanghai Medical Consulting Co. Ltd., Director at Jing Medicine Technology Shanghai Ltd., Director at Choice Technology, Inc., Director at Cheng Heng Health Science & Technology Holdings Ltd., Director at Hk Doctorlink Internet Tech Co. Ltd., Director at Shanghai Ensurlink Ltd., Director at Shanghai Yao Shi Quan Cloud Health Technology Development Ltd., Director at Start Shanghai Pharmaceutical Technology Ltd., Director at Suzhou Sceneray Corp.
Ltd., Director at Virtuoso Therapeutics, Inc., Director at AceLink Therapeutics, Inc., Director at Shanghai Jinghua Medical Management Co., Ltd., and General Manager at Shanghai Cenova Biomedicine Venture Capital Invt Co. Ltd. He has also held former positions as Director at Optomed Oyj, Director at ASLAN Pharmaceuticals Pte Ltd., Director at Shanghai Aohua Photoelectricity Endoscope Co., Ltd., Non-Executive Director at Aslan Pharmaceuticals Ltd. (2016-2021), Director at Alnair Investment, Director at Cenova China Healthcare Gp Iv Ltd., Director at Cenova Management Advisors Ltd., and Chief Scientific Officer at GNI Ltd. Dr. Wu's education includes an undergraduate degree from San Jose State University and a doctorate degree from The University of California, San Francisco.